v3.25.2
Collaborations (Tables)
6 Months Ended
Jun. 30, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Change in Accounts Receivable, Contract Asset and Liabilities

The following table presents the changes in accounts receivable, contract assets and contract liabilities for the six months ended June 30, 2025 (in thousands):

 

 

 

Balance at
December 31, 2024

 

 

Additions

 

 

Deductions

 

 

Balance at
June 30, 2025

 

Accounts receivable and contract assets:

 

 

 

 

 

 

 

 

 

 

 

 

Billed receivables - Sanofi

 

$

 

 

$

20,947

 

 

$

(20,947

)

 

$

 

Unbilled receivables - Sanofi

 

 

947

 

 

 

20,000

 

 

 

(20,947

)

 

 

 

Billed receivables - Gilead

 

 

 

 

 

40,000

 

 

 

 

 

 

40,000

 

Total accounts receivable and contract assets

 

$

947

 

 

$

80,947

 

 

$

(41,894

)

 

$

40,000

 

Contract liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Deferred revenue - Sanofi

 

$

13,576

 

 

$

20,000

 

 

$

(33,576

)

 

$

 

Deferred revenue - Gilead

 

 

 

 

 

40,000

 

 

 

 

 

 

40,000

 

Total contract liabilities

 

$

13,576

 

 

$

60,000

 

 

$

(33,576

)

 

$

40,000